FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska | Q&A with FDA

Episode 1663 of the Pharmacy Podcast Network podcast, hosted by Pharmacy Podcast Network, titled "FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska | Q&A with FDA" was published on July 24, 2023 and runs 12 minutes.

July 24, 2023 ·12m · Pharmacy Podcast Network

Summary

In this episode of Q&A with FDA, we hear from Dr. Marta Sokolowska, Deputy Center Director for Substance Use and Behavioral Health in FDA’s Center for Drug Evaluation and Research, discuss the Agency’s vision as it relates to encouraging harm reduction, including expanding availability and access to lifesaving overdose reversal products. Dr. Sokolowska delves into the impacts of the recent approvals of nonprescription naloxone nasal spray as well as prescription nalmefene nasal spray, another medication for opioid overdose.

Episode Description